A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer-Reference-Cited by-同舟云学术

A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

Published:2020-06-03 Issue:1 Volume:20 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Ulusakarya Ayhan^ORCID,Karaboué Abdoulaye,Ciacio Oriana,Pittau Gabriella,Haydar Mazen,Biondani Pamela,Gumus Yusuf,Chebib Amale,Almohamad Wathek,Innominato Pasquale F.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-020-07004-y.pdf

Reference42 articles.

1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34. https://doi: https://doi.org/10.3322/caac.21551 .

2. Hezel AF, Deshpande V, Zhu AX (2010) Genetics of biliary tract cancers and emerging targeted therapies. J Clin Oncol 28:3531–3540. https://doi: https://doi.org/10.1200/JCO.2009.27.4787 .

3. Razumilava N, Gores GJ (2014) Cholangiocarcinoma. Lancet 383:2168–2179. https://doi: https://doi.org/10.1016/s0140-6736(13)61903-0 .

4. Bridgewater J et al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60:1268–1289. https://doi: https://doi.org/10.1016/j.jhep.2014.01.021 .

5. Primrose JN et al (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 20, 663–673. https://doi: https://doi.org/10.1016/S1470-2045(18)30915-X .

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of distal cholangiocarcinoma with arterial involvement: Systematic review and case series on the role of neoadjuvant therapy;World Journal of Gastrointestinal Surgery;2024-08-27

2. A Systematised Literature Review of Real-World Treatment Patterns and Outcomes in Unresectable Advanced or Metastatic Biliary Tract Cancer;Targeted Oncology;2023-09-26

3. A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer;Investigational New Drugs;2022-12-02

4. A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer;2022-09-23

5. Case report: Conversion therapy for advanced intrahepatic cholangiocarcinoma using PD-1 inhibitor plus S-1 and nab-paclitaxel;Frontiers in Oncology;2022-07-28